Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
10/2003
10/23/2003US20030199058 Secreted and transmembrane polypeptides and nucleic acids encoding the same
10/23/2003US20030199057 Secreted and transmembrane polypeptides and nucleic acids encoding the same
10/23/2003US20030199056 PRO polypeptides; fused to heterologous polypeptide sequences
10/23/2003US20030199055 Secreted and transmembrane polypeptides and nucleic acids encoding the same
10/23/2003US20030199054 Secreted and transmembrane polypeptides and nucleic acids encoding the same
10/23/2003US20030199053 Secreted and transmembrane polypeptides and nucleic acids encoding the same
10/23/2003US20030199052 PRO polypeptides; fused to heterologous polypeptide sequences
10/23/2003US20030199051 Secreted and transmembrane polypeptides and nucleic acids encoding the same
10/23/2003US20030199044 IL-17 homologous polypeptides and therapeutic uses thereof
10/23/2003US20030199043 Therapeutic proteins (including polypeptide, antibody, peptide or fragment or variants)fused to albumin or fragment or variant linked by a linker peptide; nonglycosylated
10/23/2003US20030199042 Novel morphogenic protein
10/23/2003US20030199041 Interleukin-17 receptor homologue
10/23/2003US20030199040 First fusion polypeptide is linked to a second fusion polypeptide via disulfide bond between the heavy chain and light chain polypeptide, where in the first polypeptide binds interleukin-18
10/23/2003US20030199039 Potent and highly specific insecticidal toxin comprising 45 residues and three intramolecular disulfide bonds; method for selecting potent inhibitors of insect calcium channels
10/23/2003US20030199034 A PRO polypeptide having a full-length amino acid sequence fused to heterologous polypeptide sequences
10/23/2003US20030199033 Secreted and transmembrane polypeptides and nucleic acids encoding the same
10/23/2003US20030199032 Secreted and transmembrane polypeptides and nucleic acids encoding the same
10/23/2003US20030199031 A PRO polypeptide having a full-length amino acid sequence fused to heterologous polypeptide sequences
10/23/2003US20030199030 Secreted and transmembrane polypeptides and nucleic acids encoding the same
10/23/2003US20030199029 A PRO polypeptide having a full-length amino acid sequence fused to heterologous polypeptide sequences
10/23/2003US20030199028 Secreted and transmembrane polypeptides and nucleic acids encoding the same
10/23/2003US20030199027 Secreted and transmembrane polypeptides and nucleic acids encoding the same
10/23/2003US20030199026 A PRO polypeptide having a full-length amino acid sequence fused to heterologous polypeptide sequences
10/23/2003US20030199025 A PRO polypeptide having a full-length amino acid sequence fused to heterologous polypeptide sequences
10/23/2003US20030199024 Coded single chain trimer contains, in sequence from the N-terminus to the C-terminus: a peptide ligand segment, a first linker, a beta 2m segment, a second linker and a class I heavy chain segment
10/23/2003US20030199023 A PRO polypeptide having a full-length amino acid sequence fused to heterologous polypeptide sequences
10/23/2003US20030199022 Mutant estrogen receptors and mutant estrogen response element; wide variety of applications, including gene therapy, in vivo and in vitro expression
10/23/2003US20030199021 Secreted and transmembrane polypeptides and nucleic acids encoding the same
10/23/2003US20030199020 Chimeric heteromultimer adhesins
10/23/2003US20030199013 A preferred synthetic polypeptide having at least one antigenic site of a prion protein which only exist in nervous tissue of a mammal suffering from spongiform encephalopathy
10/23/2003US20030199012 A nucleic acid construct having a nucleic acid molecule that encodes a factor suppressing an immune response to Mycobacterium tuberculosis in a host cell
10/23/2003US20030199011 Complementary peptide ligands generated from microbial genome sequences
10/23/2003US20030199009 Modifications of apoptin
10/23/2003US20030199008 Nucleic Acids, Proteins, and antibodies
10/23/2003US20030199007 Are unique to diseased states, particularly tumors and blood-borne malignancies; useful for therapeutic purposes
10/23/2003US20030199003 High-level production of amyloid-beta peptides from IMR-32 cells
10/23/2003US20030199002 For the treatment, management, or prevention of disorders associated with abnormal expression and/ or activity of clk-2 (clock-2) nucleic acids; treating or preventing disorders associated with decreased/increased apoptosis e.g. cancer
10/23/2003US20030198994 Identification and isolation of novel DNA and the recombinant production of novel polypeptides encoded by that DNA
10/23/2003US20030198993 Secreted and transmembrane polypeptides and nucleic acids encoding the same
10/23/2003US20030198990 Androgen receptor-associated proteins, designated ARA24, ARA54, ARA55, and Rb, that interact with the androgen receptor to alter levels of androgen receptor-mediated transcriptional activation; prostrate cancer
10/23/2003US20030198989 For use as a diagnostic reagent for detecting the presence or absence of a target molecule in a sample; Systematic Evolution of Ligands by EXponential enrichment (SELEX)
10/23/2003US20030198986 Differential screening of a rat hippocampus cDNA library; a cDNA species encoding a novel protein designated Hct-1 is shown to be related to cytochromes P450
10/23/2003US20030198981 Genes and proteins involved in the biosynthesis of lipopeptides
10/23/2003US20030198976 Identifying agonists and antagonists of the polynucleotides and polypeptides of the receptor; diagnosis, treatment, and/or prevention of various diseases and/ or disorders related to these polypeptides
10/23/2003US20030198975 Proteins associated with cell growth, differentiation, and death
10/23/2003US20030198974 Method for isolating a polynucleotide of interest from the genome of a mycobacterium using a BAC-based DNA library: application to the detection of mycobacteria
10/23/2003US20030198958 Noval human proteins, polynucleotides encoding them and methods of using the same
10/23/2003US20030198957 Proteins and nucleic acids encoding same
10/23/2003US20030198956 Staged assembly of nanostructures
10/23/2003US20030198955 Novel proteins and nucleic acids encoding same
10/23/2003US20030198954 For forensic analyses, chromosome tissue/cell/organelle-specific markers, production of expression vectors, screening and diagnosis assays
10/23/2003US20030198953 For diagnosis, treatment, and prevention of related disorders
10/23/2003US20030198951 Novel methods of diagnosing colorectal cancer and/or breast cancer, compositions, and methods of screening for colorectal cancer and/or breast cancer modulators
10/23/2003US20030198949 Viral polypeptides that regulate or modulate apoptosis
10/23/2003US20030198947 Hepatitis virus sentinel virus I (SVI)
10/23/2003US20030198946 Hepatitis-C virus testing
10/23/2003US20030198942 For imparting virus resistance to Vitis scion or rootstock cultivars
10/23/2003US20030198941 Method for making an HIV vaccine
10/23/2003US20030198859 Enzymatic fuel cell
10/23/2003US20030198681 Method of making a protein polymer and uses of the polymer
10/23/2003US20030198651 Targeting antigens to the MHC class I processing pathway with an anthrax toxin fusion protein
10/23/2003US20030198650 Equine herpes viruses; hybrid nucleic acid
10/23/2003US20030198649 HBV core antigen particles with multiple immunogenic components attached via peptide ligands
10/23/2003US20030198648 Determination binding; calibration
10/23/2003US20030198647 Rheumatic diseases; autoimmune disease
10/23/2003US20030198645 Stabilized HBc chimer particles as therapeutic vaccine for chronic hepatitis
10/23/2003US20030198644 HCV peptide antigens and methods for the determination of HCV
10/23/2003US20030198642 Vaccine vehicle; induce immunology response; anticancer agents
10/23/2003US20030198641 Immunoassay, immunotherapy; antiinflammatory agents; anticancer agents
10/23/2003US20030198640 Methods and compositions for treating inflammatory bowel diseases relating to human tumor necrosis factor-gamma-beta
10/23/2003US20030198635 Treatment of ulcerative colitis with tropomyosin isoforms and monoclonal antibodies to tropomyosin isoforms
10/23/2003US20030198634 Methods of treating joint inflammation with chimeric anti-TNF antibodies
10/23/2003US20030198623 Attenuation Dna; coding cytokines, tumor antigen
10/23/2003US20030198622 vaccine including a polypeptide comprising the immunogenic portion of wilms' tumor suppressor gene(wt1); tumor-associated antigen for use in cancer immunotherapy
10/23/2003US20030198621 Polynucleotides encoding antigenic HIV type B and/or type C polypeptides, polypeptides and uses thereof
10/23/2003US20030198618 T1 receptor-like ligand II and uses thereof
10/23/2003US20030198596 Genetic engineered plasmids; diagnosis glandular disorders
10/23/2003CA2824698A1 Method of identifying transmembrane protein-interacting compounds
10/23/2003CA2521946A1 Method of identifying transmembrane protein-interacting compounds
10/23/2003CA2496631A1 Antifreeze proteins for inhibition of clathrate hydrate formation and reformation
10/23/2003CA2482938A1 Antibodies that specifically bind to tr2
10/23/2003CA2482926A1 Modified factor viii
10/23/2003CA2482893A1 Modification of the properties of a fibrin matrix with respect to growth and ingrowth of cells
10/23/2003CA2482718A1 Derivatives of the il-2 receptor gamma chain, their production and use
10/23/2003CA2482634A1 Diagnostic and therapeutic use of kremen 1 and 2, inhibitors of the canonical wnt-signal transduction
10/23/2003CA2482438A1 Plant acyl-coa synthetases
10/23/2003CA2482387A1 Derivatives of the nf-kappab inducing enzyme, their preparation and use
10/23/2003CA2482351A1 Vascularized human skin equivalent
10/23/2003CA2482262A1 Tissue defect dressings comprising a keratin network
10/23/2003CA2482244A1 Purified subfragment codifying for neuroaminidase, recombinant neuroaminidase and its use in zooprophylaxis
10/23/2003CA2482215A1 Heterogeneous protein networks crosslinked with silicone-containing links, and methods for producing them
10/23/2003CA2482126A1 Luminescent markers
10/23/2003CA2481980A1 Particle-bound human immunodeficiency virus envelope glycoproteins and related compositions and methods
10/23/2003CA2481958A1 Anti-inflammatory and wound healing effects of lymphoid thymosin .beta.-4
10/23/2003CA2481922A1 Antibodies that bind to integrin alpha-v-beta-6 and methods of use thereof
10/23/2003CA2481827A1 Polyvalent cation-sensing receptor in atlantic salmon
10/23/2003CA2481509A1 Her-2 receptor tyrosine kinase molecules and uses thereof
10/23/2003CA2481508A1 G-protein coupled receptor ligands and methods
10/23/2003CA2481503A1 Nucleic acid and corresponding protein entitled 98p4b6 useful in treatment and detection of cancer
10/23/2003CA2481462A1 Heteroclitic analogs and related methods
1 ... 1506 1507 1508 1509 1510 1511 1512 1513 1514 1515 1516 1517 1518 1519 1520 1521 1522 1523 1524 1525 1526 ... 2916